Singh, Inderjeet
Onogi, Yasuhiro https://orcid.org/0000-0002-7950-8952
Menezes, Filipe https://orcid.org/0000-0002-7630-5447
Khasanova, Dina
Kang, Lingru
Wang, Chenxi
Ruiz-Trave, Julio https://orcid.org/0009-0002-5752-7527
Sharma, Sapna https://orcid.org/0000-0003-1039-8879
Khalil, Ahmed https://orcid.org/0009-0000-2204-8636
Reichenbach, Valentin K https://orcid.org/0009-0004-4115-6201
Shi, Yingzi
Flatley, Andrew
Yan, Xiaocheng
Israel, Andreas
Dragano, Nathalia R V https://orcid.org/0000-0002-6856-5468
Aguilar-Pimentel, Juan Antonio
Hoffmann, Anne
Ghosh, Adhideb https://orcid.org/0000-0002-5160-4571
Noé, Falko https://orcid.org/0009-0002-3360-5455
Wolfrum, Christian https://orcid.org/0000-0002-3862-6805
Cucuruz, Sebastian
König, Ann-Christine
Burtscher, Ingo https://orcid.org/0000-0002-0635-3507
Hauck, Stefanie M https://orcid.org/0000-0002-1630-6827
Lickert, Heiko
Hofmann, Susanna M https://orcid.org/0000-0001-7682-5840
Feederle, Regina https://orcid.org/0000-0002-3981-367X
Schriever, Sonja C https://orcid.org/0000-0001-5461-3214
Hernandez-Bautista, Rene https://orcid.org/0000-0001-7065-2862
Sancar, Gencer https://orcid.org/0000-0002-2098-0654
Cebrian-Serrano, Alberto
Tetko, Igor https://orcid.org/0000-0002-6855-0012
Fuchs, Helmut
Gailus-Durner, Valérie
Blüher, Matthias
Hrabě de Angelis, Martin
Ussar, Siegfried https://orcid.org/0000-0001-7575-0920
Funding for this research was provided by:
government of india
Uehara Memorial Foundation (201830047)
Alexander von Humboldt-Stiftung
China Scholarship Council
Federal Ministry of Education and Research (01KX1012)
Deutsche Forschungsgemeinschaft (209933838)
Deutsches Zentrum für Diabetesforschung (82DZD00601)
EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (101120466)
Article History
Received: 4 November 2024
Revised: 15 July 2025
Accepted: 17 July 2025
First Online: 1 August 2025
Disclosure and competing interests statement
: MB received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Lilly, Novo Nordisk, Novartis, and Sanofi. All other authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.